Chitosan and alginate salt as biomaterials are potential natural adjuvants for killed cholera vaccine

被引:5
|
作者
AbdelAllah, Nourhan H. [1 ,2 ]
Gaber, Yasser [1 ,3 ]
AbdelGhani, Sameh [1 ,5 ]
Rashed, Mohamed E. [4 ]
Azmy, Ahmed F. [1 ]
机构
[1] Beni Suef Univ, Fac Pharm, Dept Microbiol & Immunol, Bani Suwayf, Egypt
[2] Egyptian Drug Author EDA, Viral Control Unit, Cairo, Egypt
[3] Mutah Univ, Fac Pharm, Dept Pharmaceut & Pharmaceut Technol, Al Karak, Jordan
[4] Egyptian Drug Author EDA, Microbiol Dept, Cairo, Egypt
[5] Univ Louisville, Sch Med, Dept Med, Louisville, KY 40202 USA
关键词
adjuvants; alginate; biopolymer; chitosan; cholera vaccine; IMMUNE-RESPONSES; DELIVERY-SYSTEMS; SUBSETS; CELLS;
D O I
10.1002/jbm.a.37240
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Chitosan and alginate salts are natural biopolymers that have gained recent attention in the biomedical sectors. Their properties allow them to become potential candidates as safe, cheap, and effective vaccine adjuvants. The present study aimed to enhance the immunogenic response of a current injectable killed cholera vaccine (KCV) using chitosan and alginate salt as natural adjuvants against alum. We tested KCV adjuvanted with alum, chitosan, and sodium alginate in mice. Mice were immunized intraperitoneally with KCV adjuvanted with alum, chitosan, or alginate salt and compared with a control unadjuvanted immunized group. Humoral, cellular, and functional immune responses were evaluated in all groups. The addition of adjuvants, particularly natural adjuvants, to KCV significantly improved the immune response as demonstrated by specific antibody increase, strong proliferation effects, and high protection rate against different challenge doses of cholera strains. Our findings demonstrate that chitosan and alginate salt are superior adjuvants for boosting the KCV immune response and highlights the requirement for further vaccine development.
引用
收藏
页码:2462 / 2470
页数:9
相关论文
共 15 条
  • [1] Immunostimulatory effect of chitosan and quaternary chitosan: A review of potential vaccine adjuvants
    Li, Xiaomin
    Xing, Ronge
    Xu, Chaojie
    Liu, Song
    Qin, Yukun
    Li, Kecheng
    Yu, Huahua
    Li, Pengcheng
    [J]. CARBOHYDRATE POLYMERS, 2021, 264
  • [2] Comparative study on alginate/chitosan microcapsules and Montanide ISA 61 as vaccine adjuvants in mice
    Silva, Laice A.
    Souza, Monique F.
    Carvalho, Thaynara P.
    Santana, Clarissa H.
    Guedes, Andressa C.
    Oliveira, Jefferson Bruno S.
    de Lima, Pamela A.
    Nogueira, Paulo Roberto A.
    Brandao, Humberto de Mello
    da Paixao, Tatiane A.
    Santos, Renato Lima
    [J]. PLOS ONE, 2024, 19 (04):
  • [3] Combining Killed Vaccine Candidate with Different Adjuvants to Determine Prophylactic Potential against Leishmaniasis
    Kelleci, Kuebra
    Allahverdiyev, Adil
    Bagirova, Melahat
    Ihlamur, Murat
    Abamor, Emrah Sefik
    [J]. ACTA PARASITOLOGICA, 2024, : 1613 - 1620
  • [4] Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis
    Thakur, Ankita
    Kaur, Harpreet
    Kaur, Sukhbir
    [J]. PARASITOLOGY INTERNATIONAL, 2015, 64 (01) : 70 - 78
  • [5] IMPAIRED IMMUNE-RESPONSE TO NATURAL INFECTION AS A CORRELATE OF VACCINE FAILURE IN A FIELD TRIAL OF KILLED ORAL CHOLERA VACCINES
    CLEMENS, J
    RAO, M
    SACK, D
    AHMED, F
    KHAN, MR
    CHAKRABORTY, J
    KAY, B
    HUDA, S
    YUNUS, M
    VANLOON, F
    SVENNERHOLM, AM
    HOLMGREN, J
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (07) : 759 - 764
  • [6] Immune Responses to the O-Specific Polysaccharide Antigen in Children Who Received a Killed Oral Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh
    Leung, Daniel T.
    Uddin, Taher
    Xu, Peng
    Aktar, Amena
    Johnson, Russell A.
    Rahman, Mohammad Arif
    Alam, Mohammad Murshid
    Bufano, Meagan Kelly
    Eckhoff, Grace
    Wu-Freeman, Ying
    Yu, Yanan
    Sultana, Tania
    Khanam, Farhana
    Saha, Amit
    Chowdhury, Fahima
    Khan, Ashraf I.
    Charles, Richelle C.
    LaRocque, Regina C.
    Harris, Jason B.
    Calderwood, Stephen B.
    Kovac, Pavol
    Qadri, Firdausi
    Ryan, Edward T.
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (06) : 780 - 788
  • [7] Memory B Cell and Other Immune Responses in Children Receiving Two Doses of an Oral Killed Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh
    Leung, Daniel T.
    Rahman, Mohammad Arif
    Mohasin, M.
    Patel, Sweta M.
    Aktar, Amena
    Khanam, Farhana
    Uddin, Taher
    Riyadh, M. Asrafuzzaman
    Saha, Amit
    Alam, Mohammad Murshid
    Chowdhury, Fahima
    Khan, Ashraful Islam
    Charles, Richelle
    LaRocque, Regina
    Harris, Jason B.
    Calderwood, Stephen B.
    Qadri, Firdausi
    Ryan, Edward T.
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (05) : 690 - 698
  • [8] Chitosan-Alginate Polymeric Nanocomposites as a Potential Oral Vaccine Carrier Against Influenza Virus Infection
    Kang, Hae-Ji
    Li, Jiaoyang
    Razzak, Md Abdur
    Eom, Gi-Deok
    Yoon, Keon-Woong
    Mao, Jie
    Chu, Ki-Back
    Jin, Hui
    Choi, Shin Sik
    Quan, Fu-Shi
    [J]. ACS APPLIED MATERIALS & INTERFACES, 2023, 15 (44) : 50889 - 50897
  • [9] Chitosan, alginate, hyaluronic acid, gums, and β-glucan as potent adjuvants and vaccine delivery systems for viral threats including SARS-CoV-2: A review
    Mallakpour, Shadpour
    Azadi, Elham
    Hussain, Chaudhery Mustansar
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 182 : 1931 - 1940
  • [10] Chitosan and Sodium Alginate Combinations Are Alternative, Efficient, and Safe Natural Adjuvant Systems for Hepatitis B Vaccine in Mouse Model
    AbdelAllah, Nourhan H.
    Abdeltawab, Nourtan F.
    Boseila, Abeer A.
    Amin, Magdy A.
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016